Article info
PDFClinical and epidemiological research
Extended report
The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study
- Correspondence to Dr Karen Minde Fagerli, Department of Rheumatology, Diakonhjemmet Hospital, Pb 23, Vinderen, Oslo 0319, Norway; karen.fagerli{at}gmail.com
Citation
The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study
Publication history
- Received July 12, 2012
- Revised October 17, 2012
- Accepted November 28, 2012
- First published January 3, 2013.
Online issue publication
February 11, 2021
Article Versions
- Previous version (11 February 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions